A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancoraycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD)

Journal of Antimicrobial Chemotherapy

Volumn 26, Issue , 1990, Pages 77-81

  Friedland, J S ^a   Iveson, T J ^a   Fraise, A P ^b   Winearls, C G ^a   Selkon, J B ^b   Oliver, D O ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GENTAMICIN; VANCOMYCIN;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL;

ADULT; AGED; CIPROFLOXACIN; COMPARATIVE STUDY; FEMALE; GENTAMICINS; HUMAN; INJECTIONS, INTRAPERITONEAL; MALE; MIDDLE AGE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; VANCOMYCIN;

EID: 0025666991     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/26.suppl_F.77     Document Type: Article

References (11)

1. Bellido, F. & Pechère, J.-C. (1989). Laboratory survey of fluoroquinolone activity. Reviews of Infectious Diseases 11, Suppl. 5, S917–24.
2. Fass, R. J. (1983). In vitro activity of ciprofloxacin (Bay o 9867). Antimicrobial Agents and Chemotherapy 24, 568–74.
3. Fleming, L. W., Moreland, T. A., Scott, A. C., Ṡtewart, W. K. & White, L. O. (1987). Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis. Journal of Antimicrobial Chemotherapy 19, 493–503.
4. Fleming, L. W., Phillips, G., Moreland, T. A., Stewart, W. K. & Scott, A. C. (1989). Oral ciprofloxacin for treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. Reviews of Infectious Diseases 11, Suppl. 5, S1294–6.
5. Gokal, R., Jakubowski, C., King, J., Hunt, L., Bogle, S., Baillod, R. et al. (1987). Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study. Lancet ii, 1105–8.
6. Golper, T. A., Hartstein, A. I., Morthland, V. H. & Christensen, J. M. (1987). Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy 31, 1787–90.
7. Michea-Hamzehpour, M., Auckenthaler, R., Regamey, P. & Pechère, J.-C. (1987). Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrobial Agents and Chemotherapy 31, 1803–8.
8. Shalit, I., Greenwood, R. B., Marks, M. I., Pederson, J. A. & Frederick, D. L. (1986). Pharmokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy 30, 152–6.
9. Wise, R., Andrews, J. M. & Edwards, L. J. (1983). In vitro activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 23, 559–64.
10. Wolfson, J. S. & Hooper, D. C. (1989). Bacterial resistance to quinolones: Mechanisms and clinical importance. Reviews of Infectious Diseases 11, Suppl. 5, S960–8.
11. Working Party of the British Society for Antimicrobial Chemotherapy (1987). Diagnosis and management of peritonitis in the management of continuous ambulatory peritoneal dialysis. Lancet i, 845–8.